Artemisia capillaris Thunb. water extract attenuates adriamycin‐induced renal injury by regulating apoptosis through the ROS/MAPK axis

• Published in: Journal of food biochemistry 2022-02, Vol.46 (2), p.e14065-n/a
• Main Authors: Huang, Guoshun, Zhu, Yiye, Yong, Chen, Tian, Fang, Liu, Li, Wu, Qijing, Shu, Yang, Yao, Min, Tang, Chenquan, Wang, Xiaofang, Chen, Wei, Zhou, Enchao
• Format: Article
• Language: English
• Subjects: adriamycin; Animals; antioxidation; anti‐apoptosis; Apoptosis; Artemisia; Artemisia capillaris Thunb; Doxorubicin - adverse effects; Kidney - physiology; Plant Extracts - therapeutic use; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; renal injury; Renal Insufficiency - chemically induced; Renal Insufficiency - drug therapy; traditional Chinese medicine; Water
• ISSN: 0145-8884; 1745-4514
• DOI: 10.1111/jfbc.14065

Artemisia capillaris Thunb. is widely used in the treatment of kidney diseases, but the underlying mechanism remain elusive. Therefore, this study aimed to elucidate the mechanism of Artemisia capillaris Thunb. in alleviating renal injury. And renoprotective effects of freeze‐dried powder of Artemisia capillaris Thunb. water extract (WAC) were assessed using adriamycin (ADR)‐induced renal injury to the NRK‐52E cells and ADR‐induced renal injury Sprague‐Dawley rats (SD rats) models. The results show that WAC could alleviate ADR‐induced renal injury in SD rats and the NRK‐52E cell line, improved renal function (BUN 9.73 ± 0.35 vs 7.13 ± 0.15, SCR 80.60 ± 1.68 vs 60.50 ± 1.42, ACR 11.50 ± 0.50 vs 8.526 ± 0.15) or cell viability (IC50 = 1.08 µg/ml (ADR), cell viability increase 36.38% ± 6.74% (added 4 mg/ml WAC)), and reduced the apoptosis. Moreover, WAC inhibited the MAPK signal transduction, increased the expression of superoxide dismutase 1 (SOD1), and decreased the production of ROS. The treatment of N‐acetylcysteine (NAC, antioxidant) in vitro showed that NAC inhibited apoptosis and alleviated renal injury by inhibiting oxidative stress and reducing the phosphorylation of proteins related to the MAPK signaling pathway. Therefore, these results suggested that WAC can alleviate ADR‐induced renal injury and apoptosis by regulating the ROS/MAPK axis and has potential to be used as a renoprotective drug. Practical applications Artemisia capillaris Thunb., which is a medicinal and edible plant, is widely used to treat kidney diseases in traditional Chinese medicine. The present research examined the renal protective effect of Artemisia capillaris Thunb. The results show that Artemisia capillaris Thunb. can effectively reduce renal tubular cell apoptosis through the ROS/MAPK axis in vivo and in vitro. In general, Artemisia capillaris Thunb. can be used as a potential herb to attenuate renal injury and further research can be conducted to explore its renoprotective mechanisms. Adriamycin (ADR)‐induced renal injury in vivo and in vitro. Freeze‐dried powder of Artemisia Capillaris Thunb. water extract (WAC) can attenuated ADR‐induced renal injury, improve antioxidant activity, suppressed MAPK signal transduction, and alleviated apoptosis in vivo and in vitro. Moreover, the NRK‐52E cells were treated with an antioxidant N‐acetylcysteine (NAC), So as to further confirm that the renal protective effects were mainly through the ROS/MAPK axis.